Position in ACHV
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$299,794
-$48,399 QoQ
Shares Held
101,971
+45.6% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 81 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 88.19370213099803.ToString("F0")%
Shared 0.ToString("F0")%
None 11.806297869001972.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,431,965 across 386 Biotechnology names. ACHV ranks #154 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ACHV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $299,794 | 101,971 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $348,193 | 70,059 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $225,527 | 71,596 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $142,502 | 63,055 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $198,300 | 74,270 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $263,763 | 74,933 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $331,202 | 69,874 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $356,635 | 75,880 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $313,062 | 68,805 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $287,950 | 69,891 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $520,217 | 120,981 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $635,738 | 122,493 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $846,756 | 124,523 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $308,626 | 125,970 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $455,294 | 137,968 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $609,867 | 124,973 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $42,338 | 5,593 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $43,513 | 5,593 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $39,014 | 4,590 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,018 | 893 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,740 | 323 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,406 | 544 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,603 | 311 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||